Tesamorelin Dosing Protocol: 10 mg Vial — Extended Supply Dosing Guide
Tesamorelin 10 mg vial guide — provides 5 days of the FDA-approved 2 mg/day dose from a single reconstitution, reducing handling frequency.
Quickstart highlights
Tesamorelin's FDA-approved 2 mg/day protocol demonstrated 15.2% visceral fat reduction at 26 weeks in Phase 3 (Falutz et al., 2010).
Concentration: 2 mg/mL (10 mg vial + 5 mL bacteriostatic water).
At 2 mg/mL: 2 mg = 100 units (full 1 mL) once daily — the FDA-approved Egrifta SV dose.
One 10 mg vial provides exactly 5 daily doses at 2 mg — reconstitute twice weekly.
Phase 3 (Falutz et al.): 2 mg/day x 26 weeks reduced visceral fat 15.2% vs. 0.7% placebo.
Refrigerate; use within 28 days.
Dosing table
For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.
1-4
1000
50
Once daily
1 mg — 50 units; 10 mg vial provides 10 doses at this level (10 days)
5-26
2000
100
2 mg — 100 units (FDA-approved dose); 10 mg vial provides 5 daily doses (5 days)
Your free Tesamorelin tracker
Dose reminders
Injection logging
Cycle progress
Reconstitution steps
Draw 5 mL bacteriostatic water in two 2.5 mL draws; inject slowly down the vial wall.
Swirl gently until powder dissolves fully; do not shake.
Final concentration: 2 mg/mL. Label with date; refrigerate at 2–8 °C. Use within 28 days.
One 10 mg vial covers 5 daily doses at 2 mg — plan reconstitution twice weekly at the 2 mg/day maintenance dose.
Supplies needed
12-week plan
12 vials
84 syringes
60 mL bac water
84 alcohol swabs
26-week plan
37 vials
182 syringes
185 mL bac water
182 alcohol swabs
Protocol overview & cycle notes
Reduce visceral adipose tissue through twice-weekly reconstitution of tesamorelin 10 mg vials at the 2 mg/day FDA-approved dose, providing 5 days of injections per reconstitution event.
Cycle length: 26 weeks on.
Off-cycle: 8 weeks off; measure IGF-1 and visceral fat surrogate (waist circumference) before resuming.
Storage & handling
Injection & tracking tips
Reconstitute twice weekly at the 2 mg/day dose — one 10 mg vial covers exactly 5 daily injections.
Inject at the same time daily (morning preferred) in the abdomen, 2 inches from the navel; rotate within quadrants.
Store used vials cap-side down in the refrigerator door; inspect for cloudiness before each draw.
Tracking
Logging helps you and your provider spot patterns and adjust dose or timing.
Measure waist circumference weekly as a visceral fat proxy.
Track IGF-1 every 8 weeks; target upper-normal for age.
Monitor fasting glucose monthly; tesamorelin can increase glucose by 5–10 mg/dL in insulin-resistant patients.
How this works & references
Sources
Metabolic effects of a growth hormone-releasing factor in patients with HIV. Falutz J et al. — N Engl J Med — 2007
FDA — Egrifta SV (tesamorelin) Prescribing Information, 2019
Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects. González-Sales M et al. — Clin Pharmacokinet — 2015
Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension. Falutz J et al. — J Acquir Immune Defic Syndr — 2010
Frequently asked questions
Related protocols
KLOW Blend Dosing Protocol — BPC-157, TB-500, KPV & GHK-Cu Guide
KLOW peptide blend (BPC-157 + TB-500 + KPV + GHK-Cu) dosing guide for tissue repair, anti-inflammatory support, and extracellular matrix remodeling — the GLOW blend plus KPV.
GLOW Blend Dosing Protocol — BPC-157, TB-500 & GHK-Cu Skin & Repair Guide
GLOW peptide blend (BPC-157 + TB-500 + GHK-Cu) dosing guide for tissue repair, angiogenesis, and collagen and connective-tissue remodeling.
Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide
Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.
Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide
Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.
This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.
Need help?